Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chronic graft versus host disease.

Meghan A Higman¹, Georgia B Vogelsang

¹The Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore, MD, USA.

British Journal of Haematology

|May 15, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute hepatic encephalopathy and multiorgan failure in sickle cell disease and COVID-19.

Pediatric blood & cancer·2021

Same author

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

Blood advances·2020

Same author

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2015

Same author

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2015

Same author

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2015

Same author

2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2015

Long-term survivors of stem cell transplants face chronic graft versus host disease (GvHD). This review details risk factors, presentations, and treatments for GvHD to improve patient outcomes.

Area of Science:

Hematology
Immunology
Oncology

Background:

Stem cell transplantation offers cures for various diseases, leading to more long-term survivors.
Chronic graft versus host disease (GvHD) is a significant complication in allogeneic stem cell transplantation.
Increasing use of alternative stem cell sources and immunomodulation may increase GvHD incidence.

Purpose of the Study:

To review risk factors for developing chronic GvHD.
To describe the multi-organ system presentations of chronic GvHD.
To outline current treatment options for chronic GvHD.

Main Methods:

Literature review of risk factors, clinical presentations, and treatment strategies for chronic GvHD.
Synthesis of current knowledge on GvHD management.

Related Experiment Videos

Focus on identification and therapeutic approaches for hematologists/oncologists.

Main Results:

Identified key risk factors contributing to chronic GvHD development.
Detailed the diverse clinical manifestations across multiple organ systems.
Summarized established and emerging treatment modalities for initial and secondary GvHD therapy.

Conclusions:

Effective management of chronic GvHD is crucial for improving quality of life in stem cell transplant survivors.
Early identification and understanding of GvHD's varied presentations are essential for clinicians.
Current treatment options aim to mitigate GvHD's impact, but further research is needed.